Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 17, 2026

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
07:24

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing

Published on: February 10, 2023

Biomarker Validation for Aging: Lessons from mtDNA Heteroplasmy Analyses in Early Cancer Detection.

Peter E Barker1, Mahadev Murthy

  • 1Bioassay Methods Group, Biochemical Sciences Division, Bldg 227/B248, NIST, 100 Bureau Drive, Gaithersburg, Maryland.

Biomarker Insights
|December 24, 2009
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Invertebrates as model organisms for research on aging biology.

Invertebrate reproduction & development·2015
Same author

Blue journal conference. Aging and susceptibility to lung disease.

American journal of respiratory and critical care medicine·2015
Same author

Acute kidney injury in older adults.

Journal of the American Society of Nephrology : JASN·2011
Same author

Quantitative infrared spectroscopy of formalin-fixed, paraffin-embedded tissue specimens: paraffin wax removal with organic solvents.

Applied immunohistochemistry & molecular morphology : AIMM·2009
Same author

Performance of mitochondrial DNA mutations detecting early stage cancer.

BMC cancer·2008
Same author

Quantitation of HER2 and telomerase biomarkers in solid tumors with IgY antibodies and nanocrystal detection.

International journal of cancer·2008

Mitochondrial DNA (mtDNA) shows promise as a biomarker for aging and cancer. Further research is needed to understand the relationship between mtDNA changes and these conditions for accurate biomarker development.

Area of Science:

  • Biochemistry
  • Genetics
  • Biomarker Discovery

Background:

  • Biomarkers for aging and cancer detection are of significant interest.
  • Mitochondrial DNA (mtDNA) is being evaluated as a potential biomarker in both aging and cancer.
  • The exact relationship between mtDNA changes in aging and cancer remains unclear.

Purpose of the Study:

  • To evaluate mitochondrial DNA (mtDNA)-based biomarkers.
  • To explore emerging strategies for quantifying mtDNA admixtures.
  • To understand how new technologies evolve the understanding of mtDNA in aging and cancer.

Main Methods:

  • Review and evaluation of existing studies on mtDNA biomarkers.
  • Analysis of emerging technologies for mtDNA admixture quantitation.
Keywords:
agingbiomarkercancerearly cancer detectioneconomic impacthealthcareheteroplasmymitochondrial DNA (mtDNA) sequencingmitochondriomemutationnext generation DNA sequencing (NGS)reactive oxygen species (ROS)surface-enhanced laser desorption ionization-based mass spectrometry (SELDI-MS)technologyvalidation

More Related Videos

Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

Related Experiment Videos

Last Updated: Jun 17, 2026

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
07:24

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing

Published on: February 10, 2023

Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

  • Comparison of analytical technologies and biomarker analytes.

    • Main Results:

    • Biological systems are dynamic and heterogeneous.
    • Detection limits for mtDNA sequencing vary across methods for low-level DNA admixtures.
    • Distinguishing measurement system variance from biological variance is critical for biomarker evaluation.

    Conclusions:

    • Lessons from mtDNA biomarker evaluations highlight the dynamic and heterogeneous nature of biological systems.
    • Analytical mtDNA technologies require validation for application in complex biological systems.
    • Accurate biomarker performance evaluation necessitates differentiating technical noise from biological signals.